Category Archives: ADVISORY: American Botanical Council Submits Comments to FDA Suggesting Rescheduling of Cannabis

ADVISORY: American Botanical Council Submits Comments to FDA Suggesting Rescheduling of Cannabis

ABC ADVISORY American Botanical Council Submits Comments to FDA Suggesting Rescheduling of Cannabis ABC highlights clinical research supporting therapeutic benefits, noting that current Schedule I drug status significantly impedes research efforts on cannabis, cannabis preparations, and its compounds AUSTIN, Texas (April 26, 2018) — The nonprofit American Botanical Council (ABC) recently submitted comments to the US Food and Drug Administration (FDA) noting

Read more